Retrospective observational study of the use of artemether-lumefantrine in the treatment of malaria in Japan

The Research Group on Chemotherapy of Tropical Diseases, Japan, introduced artemether –lumefantrine (AL) in late 2002, mainly for treating uncomplicated Plasmodium falciparum malaria. Because AL was on the market in Japan in March 2017, the effectiveness and safety of AL were analyzed to help medical personnel use AL optimally.

Source: Travel Medicine and Infectious Disease - February 15, 2018 Category: Infectious Diseases Authors: Fukumi Nakamura-Uchiyama, Yuichi Katanami, Tadashi Kikuchi, Saho Takaya, Satoshi Kutsuna, Taiichiro Kobayashi, Yasutaka Mizuno, Tetsuo Hasegawa, Michiko Koga, Yukihiro Yoshimura, Chihiro Hasegawa, Yasuyuki Kato, Mikio Kimura, Haruhiko Maruyama, for the Re Source Type: research